Results 1 to 3 of 3

Thread: Getting drunk without the hangover

  1. #1
    Mergie Master's Avatar
    Mergie Master is offline Dedicated Tamiecide Practitioner
    Join Date
    Sep 2001
    Location
    Saluca (not Saluda)
    Posts
    71,579

    Default Getting drunk without the hangover

    Getting drunk without the hangover or health risks – scientist seeks investment for ‘alcohol substitute’ drug

    Former Government drugs adviser Professor David Nutt says his team are on the brink of a ‘serious revolution in health’ – but he needs help getting round the powerful drinks industry

    Scientists are developing a drug which mimics all the positive effects of being drunk without any of the health risks, addiction – or hangovers.

    The “serious revolution in health” is being pioneered by the former Government drugs adviser Professor David Nutt, and has been described as doing for alcohol what the e-cigarette has done for tobacco use.

    It targets neurotransmitters in the brain directly, giving the taker feelings of pleasure and dis-inhibition that are in some cases “indistinguishable” from the effects of drinking. Yet because it acts directly, it can also be immediately blocked by taking an antidote – with “drinkers” potentially able to then drive or return to work straight away.

    Prof Nutt is one of the country’s leading neuropsychopharmacologists, but he and his team at Imperial College London have hit a stumbling block – perhaps unsurprisingly, no one in the drinks industry is willing to fund the drug’s development.

    Speaking to the Dragon’s Den presenter Evan Davis on the BBC’s Today program this morning, Prof Nutt appealed for investors to come forward and support his ground-breaking research.

    He said: “I think this would be a serious revolution in health... just like the e-cigarette is going to revolutionize the smoking of tobacco.

    “I find it weird that we haven't been speaking about this before, as it's such a target for health improvement.”

    One of the biggest benefits to Prof Nutt’s alcohol substitute would be to remove addiction as a drinking problem. The scientist said 10 per cent of drinkers become addicted, and that addicts account for most of the one and a half million people killed by alcohol every year.

    The Professor said that the drug would be taken in the form of a range of cocktails, and added: “I’ve done the prototype experiments myself many years ago, where I’ve been inebriated and then it’s been reversed by the antagonist.

    “That’s what really gave us the idea. There’s no question that you can produce a whole range of effects like alcohol by manipulating the brain.”
    The Elites don't fear the tall nails, government possesses both the will and the means to crush those folks. What the Elites do fear (or should fear) are the quiet men and women, with low profiles, hard hearts, long memories, and detailed target folders for action as they choose.

    "I here repeat, & would willingly proclaim, my unmitigated hatred to Yankee rule—to all political, social and business connections with Yankees, & to the perfidious, malignant, & vile Yankee race."

  2. #2
    Mergie Master's Avatar
    Mergie Master is offline Dedicated Tamiecide Practitioner
    Join Date
    Sep 2001
    Location
    Saluca (not Saluda)
    Posts
    71,579

    Default

    There's already something you can buy (online) that does the same thing. Or so I've heard....(sh!t will probably kill you dead as a doorknob if you ain't a Ruskie)

    Phenibut

    β-Phenyl-γ-aminobutyric acid (brand name Noofen), better known as phenibut or less commonly fenibut or phenybut, is a derivative of the naturally occurring inhibitory neurotransmitter γ-aminobutyric acid (GABA). The addition of a phenyl ring allows phenibut to cross the blood brain barrier. Phenibut is sold as a nutritional supplement, and is not approved as a pharmaceutical in the United States or Europe, but in Russia it is sold as a psychotropic drug. It has been reported by some to possess nootropic actions for its ability to improve neurological functions, but other researchers have not observed these effects. It is generally accepted that phenibut has anxiolytic effects in both animal models and in humans. Phenibut was discovered in the Soviet Union in the 1960s, and has since been used there to treat a wide range of ailments including post-traumatic stress disorder, anxiety, and insomnia.

    The name phenibut, along with many of the other names for the compound, comes directly from the chemical name for the compound, β-phenyl-γ-aminobutyric acid.

    History

    Phenibut was synthesized at the I. M. Herzen Leningrad Pedagogical Institute USSR and the Institute of Experimental Medicine, Academy of Medical Sciences USSR by Professor V. V. Perekalin's team.

    Phenibut is mandated standard equipment in a Russian cosmonaut's medical kit. The use of "conventional" tranquilizers for stress and anxiety makes patients drowsy, which was deemed unacceptable for cosmonauts; phenibut, however, lowers stress levels without adversely affecting performance. In 1975 phenibut was included in the cosmonauts' kit for those who participated in the Apollo-Soyuz joint mission.

    General information

    In chemical structure, phenibut is a phenyl derivative of GABA. Although the calming action is similar to other GABA agonists, phenibut binds to the GABAB metabotropic receptor, the same site responsible for the sedative effects of baclofen (the para-chloro derivative of phenibut) and γ-hydroxybutyrate (GHB), although GHB also acts at the GHB receptor.[6] There is dispute in the literature about whether or not phenibut binds to the GABAA ionotropic receptor, which is responsible for the actions of the benzodiazepines, barbiturates, z-drugs, and for some of the effects of ethanol. According to Allikmets and Ryage (1983) and Shulgina (1986) phenibut does bind to the GABAA receptor, but according to Lapin (2001) it does not. In the case of the former, it is argued that the GABAA binding only occurs at higher concentrations.

    The literature that supports the nootropic effects of phenibut also suggest it elicits tranquilizing effects, reduction of stress and anxiety, improvement of impaired sleep, and the potentiation of the effects of tranquilizers, narcotics, and neuroleptics. It is also suggested to have an anticonvulsant effect, though studies on other GABAB agonists, such as GHB and the phenibut analogue baclofen, have shown them to act as potential convulsants. It should be noted, however, that GHB acts on the convulsion-inducing GHB receptor, which phenibut does not.

    Physical properties

    Phenibut HCl is a white crystalline powder and the taste is very sour. It is readily soluble in water, soluble in alcohol, and the pH of a 2.5% water solution is between about 2.3 and 2.7.

    Doses

    Commonly recommended doses are 250–1500 mg, twice daily, or as needed. This is up to the discretion of the health care practitioner as it pertains to patient needs. At doses above 40 mg/kg, a lowering of body temperature may occur along with muscle relaxation.

    Chemistry

    Structurally, phenibut is a γ-aminobutyric acid with a phenyl group in the β-position. It is a chiral molecule and thus has two potential configurations, an (R)- and (S)-enantiomer. In phenibut, only the (R)-enantiomer is biologically active leaving the (S)-enantiomer of little value. It has the same structure of baclofen (lacking only a chlorine atom in the para-position of the phenyl group) and includes the phenylethylamine structure.

    Pharmacology

    The pharmacological effects of phenibut are similar to baclofen, but less potent per milligram of dosage.

    Phenibut exerts its effects by being an agonist at the metabotropic GABAB receptor, and at higher doses also at the ionotropic GABAA receptor.

    Some studies found that phenibut antagonizes the effects of phenylethylamine (PEA), while others found no effect on PEA induced anxiety.

    Furthermore, phenibut has been shown to enhance levels of dopamine.

    Contraindications and side effects

    The literature reports that phenibut has almost no negative side effects, with only an increase in sleepiness observed, however this effect is not nearly as pronounced as with benzodiazepine usage. Tolerance has been reported with extended use of high doses (e.g. 5–10 grams) of phenibut.

    There are numerous reports of withdrawal symptoms on Internet forums and blogs. They seem mainly due to misuse or excess. There is one reported case of withdrawal involving "nervousness and shakiness, psychomotor agitation, feeling easily annoyed and irritated, fatigue, poor appetite, heart pounding and racing, nausea, insomnia, and feeling tense and keyed up", consistent with its GABAB agonist properties. There has been no systematic study of this problem.

    Persons on MAO inhibitors or epilepsy medications like carbamazepine or oxcarbazepine should consult with their physician or pharmacist prior to supplementation with phenibut. Some evidence suggests that phenibut can modulate the function of some epilepsy medications.
    The Elites don't fear the tall nails, government possesses both the will and the means to crush those folks. What the Elites do fear (or should fear) are the quiet men and women, with low profiles, hard hearts, long memories, and detailed target folders for action as they choose.

    "I here repeat, & would willingly proclaim, my unmitigated hatred to Yankee rule—to all political, social and business connections with Yankees, & to the perfidious, malignant, & vile Yankee race."

  3. #3
    Join Date
    Nov 2005
    Location
    Meeksico
    Posts
    13,642

    Default

    Been around for years and all natural
    They say the only time a fishermen tells the truth is when he tells you another fisherman is a liar.

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •